Harbour Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Harbour Investments's ARKG Position: Q2 2026 in Review
Harbour Investments reduced its ARK Genomic Revolution ETF (ARKG) stake by 31% in Q2 2026, selling an estimated $27.6K and leaving 1,967 shares worth $82.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.
Harbour Investments first reported a position in ARKG in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.14M in Q2 2021. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Harbour Investments held 1,967 shares of ARK Genomic Revolution ETF worth $82.7K as of Q2 2026.
- Harbour Investments sold 868 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $27.6K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2129 holding.
- Harbour Investments first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 21 quarters since.
- Harbour Investments's ARK Genomic Revolution ETF position peaked at $2.14M in Q2 2021.
- 274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.